"Investment activity and portfolio operating trends are tracking ahead of budgeted expectations, allowing us to once again increase our 2026 AFFO per share guidance to a new range of $2.01 to $2.05 ...
Do you really need to watch Christopher Nolan's The Odyssey on an IMAX 70mm screen to experience it the way the director ...
1d
Lockheed Martin raises 2026 outlook to $79.75B-$81.75B in sales, driven by munitions and F-35 ramps
Q2 2026 earnings call: raised guidance, $230B backlog, $2.9B FCF, THAAD $35B win, ramps & risks—read key takeaways.
Nick Wuest, senior manager of culinary innovation, has expanded the line of shakes, lemonades, teas, and more at the fast ...
From a Times Square legend to a Jersey City newcomer, these five hotels are giving the classic cocktail its due.
Barchart on MSN
UBS says Micron could buy back nearly half its stock. Why I’m not counting on that MU catalyst.
Micron (MU) stock has been on a downward trajectory since the June 24 earnings report. I previously reported that the selloff ...
Associated Banc (NYSE:ASB) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. Fo ...
AT&T Inc. (NYSE: T) reported strong second-quarter results, driven by consistent execution of the Company's investment-led ...
If distilled, the story of Fevertree Drinks (FEVR) reminds us of the truism that high ratings can only be maintained if they’re matched by proportional earnings growth. The greater the divergence ...
Bell Potter analyst John Hester maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$19.00. Claim 55% Off TipRanks. Unlock powerful investing tools w ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results